Filing Flows › Dogwood Therapeutics (DWTX) › Who owns the stock
Who owns Dogwood Therapeutics (DWTX) stock
16 funds reported Dogwood Therapeutics (DWTX) shares in their latest 13F filings, worth $6.3M in all. The largest holder is Armistice Capital, LLC ($5.0M). Last quarter 7 funds added to their stakes and 6 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Armistice Capital, LLC | 3,132,486 | $5.0M | decrease | 2026-06-30 |
| Millennium Management LLC | 341,814 | $550K | new | 2026-06-30 |
| Vanguard Capital Management LLC | 132,154 | $213K | unchanged | 2026-06-30 |
| Geode Capital Management, LLC | 88,298 | $142K | increase | 2026-06-30 |
| Vanguard Group | 29,955 | $125K | increase | 2025-12-31 |
| Vanguard Fiduciary Trust | 62,736 | $101K | unchanged | 2026-06-30 |
| BlackRock | 28,546 | $46K | increase | 2026-06-30 |
| Northern Trust | 23,779 | $38K | unchanged | 2026-06-30 |
| Citadel Advisors LLC | 11,742 | $19K | new | 2026-06-30 |
| Tower Research Capital LLC | 3,093 | $5K | decrease | 2026-06-30 |
| Morgan Stanley | 2,222 | $4K | new | 2026-06-30 |
| UBS Group AG | 1,860 | $3K | decrease | 2026-06-30 |
| Jones Financial Companies Lllp | 160 | $264 | new | 2026-06-30 |
| BFC Planning | 20 | $32 | unchanged | 2026-06-30 |
| Group One Trading LLC | 9 | $14 | unchanged | 2026-06-30 |
Dogwood Therapeutics' latest quarter
Dogwood Therapeutics, Q3 2026: revenue $100K, net loss $4.9M, operating cash flow −$4.6M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most DWTX stock?
By the latest 13F filings: Armistice Capital, LLC ($5.0M); Millennium Management LLC ($550K); Vanguard Capital Management LLC ($213K); Geode Capital Management, LLC ($142K); Vanguard Group ($125K).
What is the short interest in DWTX?
62,406 shares were sold short at the 2026-10-15 settlement, 60.45% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.